Progression of Coronary Atherosclerosis in MACS

MACS 中冠状动脉粥样硬化的进展

基本信息

  • 批准号:
    9047317
  • 负责人:
  • 金额:
    $ 72.14万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2014
  • 资助国家:
    美国
  • 起止时间:
    2014-08-07 至 2018-04-30
  • 项目状态:
    已结题

项目摘要

DESCRIPTION (provided by applicant): Observational studies suggest that HIV infection is associated with an increased incidence of cardiovascular disease (CVD) events, including coronary heart disease and sudden cardiac death (SCD), compared to the general population; however, the specific mechanisms leading to this increased risk are not well defined. The Multicenter AIDS Cohort Study (MACS) is an observational cohort study of men who have sex with men (MSM) that includes both HIV-infected (HIV+) and -uninfected (HIV-) participants. We have measured subclinical coronary atherosclerosis by coronary computed tomography angiography (CCTA) in 764 men in the MACS. We found a greater prevalence and extent of non-calcified coronary plaque among HIV+ than HIV- men. Older age was associated with a greater prevalence of non-calcified plaque in HIV+ men, but not HIV- individuals, in cross-sectional analyses of these 40-70-year old men. To clearly define the progression of coronary plaque in HIV+ treated people, a longitudinal CCTA study is needed. We propose a study to determine whether aging HAART-treated HIV+ men experience greater progression of non-calcified plaque volume than HIV- men. We will also identify plaques with specific features that characterize them as potentially vulnerable (i.e., plaques with low attenuation, outward remodeling, and spotty calcification) and put them at high risk for causing acute coronary syndromes. Emerging evidence suggests that HIV+ persons may be at increased risk for sudden cardiac death (SCD) and heart failure (HF) compared to the general population. We will evaluate left ventricular ejection fraction (EF) and myocardial perfusion abnormalities, since these are known to predispose to CVD events, including SCD and HF, and have not been well studied among HIV+ persons. Thus, this proposal will leverage an existing research infrastructure to achieve the following specific aims: Specific Aim 1: determine whether aging HIV+ men have a greater progression of non-calcified coronary atherosclerotic plaque than HIV- men over 4-6 years of follow-up. Secondary aims are to determine whether, compared to HIV- men, HIV+ men have a) a greater incidence of new non-calcified plaque and/or slower rates of transition from non-calcified to calcified plaque in individual coronary segments and b) a greater prevalence and incidence of high risk vulnerable plaques Specific Aim 2: determine whether HIV+ men are more likely than HIV- men to have myocardial abnormalities that could predispose them to SCD and HF. We will compare a) left ventricular EF and b) global myocardial perfusion index between HIV+ and HIV- men. Secondary aims include a comparison of the prevalences of left ventricular myocardial scar and resting perfusion abnormalities. The proposed studies will lead to a greater understanding of the pathogenesis and dynamics of CVD among HAART-treated HIV+ persons, knowledge which can then be used to develop effective CVD prevention strategies.
描述(由申请人提供):观察性研究表明,与一般人群相比,HIV感染与心血管疾病(CVD)事件(包括冠心病和心源性猝死(SCD))的发生率增加相关;然而,导致这种风险增加的具体机制尚未明确。多中心艾滋病队列研究(MACS)是一项针对男男性行为者(MSM)的观察性队列研究,包括HIV感染者(HIV+)和未感染者(HIV-)。我们通过冠状动脉计算机断层扫描血管造影术(CCTA)测量了764名MACS男性的亚临床冠状动脉粥样硬化。我们发现HIV阳性者的非钙化性冠状动脉斑块的患病率和程度高于HIV阴性者。在对这些40-70岁男性的横断面分析中,年龄较大与艾滋病毒阳性男性非钙化斑块的患病率较高相关,但与艾滋病毒阴性男性无关。为了明确定义HIV+治疗人群中冠状动脉斑块的进展,需要进行纵向CCTA研究。我们提出了一项研究,以确定是否老化HAART治疗的HIV+男性经历更大的进展,非钙化斑块体积比HIV-男性。我们还将识别具有特定特征的斑块,这些特征将其表征为潜在的脆弱性(即,低衰减、向外重塑和点状钙化的斑块),并使它们处于引起急性冠状动脉综合征的高风险中。新出现的证据表明,与普通人群相比,HIV阳性者发生心脏性猝死(SCD)和心力衰竭(HF)的风险可能会增加。我们将评估左心室射血分数(EF)和心肌灌注异常,因为已知这些是CVD事件的易感因素,包括SCD和HF,并且尚未在HIV+人群中进行充分研究。因此,该提案将利用现有的研究基础设施来实现以下具体目标:具体目标1:确定在4-6年的随访中,老年HIV+男性的非钙化冠状动脉粥样硬化斑块的进展是否比HIV-男性更大。次要目的是确定与HIV-男性相比,HIV+男性是否a)新发非钙化斑块的发生率更高和/或个体冠状动脉段中非钙化斑块向钙化斑块转变的速率更慢,以及B)高危易损斑块的患病率和发生率更高。确定HIV阳性男性是否比HIV阴性男性更容易发生心肌异常,从而使他们易患SCD和HF。我们将比较HIV阳性和HIV阴性男性之间的a)左心室EF和B)总体心肌灌注指数。次要目的包括比较左心室心肌瘢痕和静息灌注异常的发生率。拟议的研究将导致更好地了解HAART治疗的HIV+人群中CVD的发病机制和动力学,这些知识可用于制定有效的CVD预防策略。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

WENDY S POST其他文献

WENDY S POST的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('WENDY S POST', 18)}}的其他基金

Progression of Coronary Atherosclerosis in MACS
MACS 中冠状动脉粥样硬化的进展
  • 批准号:
    9269250
  • 财政年份:
    2014
  • 资助金额:
    $ 72.14万
  • 项目类别:
Progression of Coronary Atherosclerosis in MACS
MACS 中冠状动脉粥样硬化的进展
  • 批准号:
    8790664
  • 财政年份:
    2014
  • 资助金额:
    $ 72.14万
  • 项目类别:
Identifying Risk Factors for Subclinical Myocardial Disease in HIV Infection
确定 HIV 感染中亚临床心肌病的危险因素
  • 批准号:
    9330904
  • 财政年份:
    2014
  • 资助金额:
    $ 72.14万
  • 项目类别:
Subclinical Vascular Disease and Metabolic Abnormalities in MACS
MACS 中的亚临床血管疾病和代谢异常
  • 批准号:
    8300148
  • 财政年份:
    2008
  • 资助金额:
    $ 72.14万
  • 项目类别:
Subclinical Vascular Disease and Metabolic Abnormalities in MACS
MACS 中的亚临床血管疾病和代谢异常
  • 批准号:
    7881417
  • 财政年份:
    2008
  • 资助金额:
    $ 72.14万
  • 项目类别:
Subclinical Vascular Disease and Metabolic Abnormalities in MACS
MACS 中的亚临床血管疾病和代谢异常
  • 批准号:
    7691240
  • 财政年份:
    2008
  • 资助金额:
    $ 72.14万
  • 项目类别:
Subclinical Vascular Disease and Metabolic Abnormalities in MACS
MACS 中的亚临床血管疾病和代谢异常
  • 批准号:
    8112655
  • 财政年份:
    2008
  • 资助金额:
    $ 72.14万
  • 项目类别:
LONGEVITY IN THE AMISH
阿米什人的长寿
  • 批准号:
    7604558
  • 财政年份:
    2006
  • 资助金额:
    $ 72.14万
  • 项目类别:
LONGEVITY IN THE AMISH
阿米什人的长寿
  • 批准号:
    7378820
  • 财政年份:
    2005
  • 资助金额:
    $ 72.14万
  • 项目类别:
MESA Family Study
MESA家庭研究
  • 批准号:
    7114801
  • 财政年份:
    2003
  • 资助金额:
    $ 72.14万
  • 项目类别:

相似国自然基金

靶向递送一氧化碳调控AGE-RAGE级联反应促进糖尿病创面愈合研究
  • 批准号:
    JCZRQN202500010
  • 批准年份:
    2025
  • 资助金额:
    0.0 万元
  • 项目类别:
    省市级项目
对香豆酸抑制AGE-RAGE-Ang-1通路改善海马血管生成障碍发挥抗阿尔兹海默病作用
  • 批准号:
    2025JJ70209
  • 批准年份:
    2025
  • 资助金额:
    0.0 万元
  • 项目类别:
    省市级项目
AGE-RAGE通路调控慢性胰腺炎纤维化进程的作用及分子机制
  • 批准号:
  • 批准年份:
    2024
  • 资助金额:
    0 万元
  • 项目类别:
    面上项目
甜茶抑制AGE-RAGE通路增强突触可塑性改善小鼠抑郁样行为
  • 批准号:
    2023JJ50274
  • 批准年份:
    2023
  • 资助金额:
    0.0 万元
  • 项目类别:
    省市级项目
蒙药额尔敦-乌日勒基础方调控AGE-RAGE信号通路改善术后认知功能障碍研究
  • 批准号:
  • 批准年份:
    2022
  • 资助金额:
    33 万元
  • 项目类别:
    地区科学基金项目
LncRNA GAS5在2型糖尿病动脉粥样硬化中对AGE-RAGE 信号通路上相关基因的调控作用及机制研究
  • 批准号:
  • 批准年份:
    2022
  • 资助金额:
    10.0 万元
  • 项目类别:
    省市级项目
围绕GLP1-Arginine-AGE/RAGE轴构建探针组学方法探索大柴胡汤异病同治的效应机制
  • 批准号:
    81973577
  • 批准年份:
    2019
  • 资助金额:
    55.0 万元
  • 项目类别:
    面上项目
AGE/RAGE通路microRNA编码基因多态性与2型糖尿病并发冠心病的关联研究
  • 批准号:
    81602908
  • 批准年份:
    2016
  • 资助金额:
    18.0 万元
  • 项目类别:
    青年科学基金项目
高血糖激活滑膜AGE-RAGE-PKC轴致骨关节炎易感的机制研究
  • 批准号:
    81501928
  • 批准年份:
    2015
  • 资助金额:
    18.0 万元
  • 项目类别:
    青年科学基金项目

相似海外基金

The Phenomenon of Stem Cell Aging according to Methylation Estimates of Age After Hematopoietic Stem Cell Transplantation
根据造血干细胞移植后甲基化年龄估算干细胞衰老现象
  • 批准号:
    23K07844
  • 财政年份:
    2023
  • 资助金额:
    $ 72.14万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Analysis of Age-dependent Functional Changes in Skeletal Muscle CB1 Receptors by an in Vitro Model of Aging-related Muscle Atrophy
通过衰老相关性肌肉萎缩的体外模型分析骨骼肌 CB1 受体的年龄依赖性功能变化
  • 批准号:
    22KJ2960
  • 财政年份:
    2023
  • 资助金额:
    $ 72.14万
  • 项目类别:
    Grant-in-Aid for JSPS Fellows
Joint U.S.-Japan Measures for Aging and Dementia Derived from the Prevention of Age-Related and Noise-induced Hearing Loss
美日针对预防与年龄相关和噪声引起的听力损失而导致的老龄化和痴呆症联合措施
  • 批准号:
    23KK0156
  • 财政年份:
    2023
  • 资助金额:
    $ 72.14万
  • 项目类别:
    Fund for the Promotion of Joint International Research (International Collaborative Research)
The Effects of Muscle Fatigability on Gait Instability in Aging and Age-Related Falls Risk
肌肉疲劳对衰老步态不稳定性和年龄相关跌倒风险的影响
  • 批准号:
    10677409
  • 财政年份:
    2023
  • 资助金额:
    $ 72.14万
  • 项目类别:
Characterizing gut physiology by age, frailty, and sex: assessing the role of the aging gut in "inflamm-aging"
按年龄、虚弱和性别表征肠道生理学特征:评估衰老肠道在“炎症衰老”中的作用
  • 批准号:
    497927
  • 财政年份:
    2023
  • 资助金额:
    $ 72.14万
  • 项目类别:
Deciphering the role of osteopontin in the aging eye and age-related macular degeneration
破译骨桥蛋白在眼睛老化和年龄相关性黄斑变性中的作用
  • 批准号:
    10679287
  • 财政年份:
    2023
  • 资助金额:
    $ 72.14万
  • 项目类别:
Role of AGE/RAGEsignaling as a driver of pathological aging in the brain
AGE/RAGE信号传导作为大脑病理性衰老驱动因素的作用
  • 批准号:
    10836835
  • 财政年份:
    2023
  • 资助金额:
    $ 72.14万
  • 项目类别:
Elucidation of the protein kinase NLK-mediated aging mechanisms and treatment of age-related diseases
阐明蛋白激酶NLK介导的衰老机制及年龄相关疾病的治疗
  • 批准号:
    23K06378
  • 财政年份:
    2023
  • 资助金额:
    $ 72.14万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Underlying mechanisms of age-related changes in ingestive behaviors: From the perspective of the aging brain and deterioration of the gustatory system.
与年龄相关的摄入行为变化的潜在机制:从大脑老化和味觉系统退化的角度来看。
  • 批准号:
    23K10845
  • 财政年份:
    2023
  • 资助金额:
    $ 72.14万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Targeting Age-Activated Proinflammatory Chemokine Signaling by CCL2/11 to Enhance Skeletal Muscle Regeneration in Aging
通过 CCL2/11 靶向年龄激活的促炎趋化因子信号传导以增强衰老过程中的骨骼肌再生
  • 批准号:
    478877
  • 财政年份:
    2023
  • 资助金额:
    $ 72.14万
  • 项目类别:
    Operating Grants
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了